Respuesta de los autores: Efecto del valor de la hemoglobina en la supervivencia del cáncer de pulmón

González Barcala, Francisco Javier; Cuadrado, Luis Valdés; García Prim, José María; Pose Reino, Antonio.
Med. clín (Ed. impr.) ; 133(11): 444-445, sept. 2009.
Artículo en Español | IBECS (España) | ID: ibc-76887

Documentos relacionados

  1. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
  2. Aspartate Transaminase-to-Albumin Ratio (ATAR), a Novel Prognostic Index, Predicts Outcomes in Patients with Small-Cell Lung Cancer.
  3. [Wedge Resection in Poor Risk Patients with Clinical-N0 Pure Solid Lung Cancer].
  4. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis.
  5. Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients.
  6. [Impact of hemoglobine level on lung cancer survival].
  7. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer.
  8. High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma.
  9. p38 MAP kinases: plausible diagnostic and prognostic serum protein marker of non small cell lung cancer.
  10. Prognostic significance of serum osteopontin levels in small cell lung cancer.